1Vincent DeVitat,Steven A.Rosenberg,Cancer principles and practice of oncology,Philadelphia,Lippincott Willians& Wikins,2001.10-11.
2Richrd J.Simpson,Proteins and Proteomics:a Laboratory Mannual,New York,Cold spring Harbor Laboratory Press,2003.12-15.
3Pennington S ,Dunn MJ,Dunn M.Proteomics:from protein sequence to function,New York,Bios Scientific Publishers Limited,2001.22.
4Daniel DV.The future of cancer research,Oncol Issues 2002,17:38-40.
5Petricoin EF,Ardekani AM,Hitt BA,et al.Use of proteomic patterns in serum to identify ovarian cancer.Lancet,2002,359:572-577.
6Patricia A,Fetsch MT,Nicole L.Simone,proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry ,Am J Clin Pathol,2002.118:870-876.
7Kammouni WA,Prieto DR,Issaq H.SELDI as a proteomic approach for biomarker identification of normal lung type II cells and adenocarcinoma.Program and abstracts of the Annual Meeting of the American Association for Cancer Research,2003.5-9.Toronto,Ontario,C
8Xiao Z,Adam BL,Cazares L,et al.Quantitation of prostate specific membrane antigen by a novel protein biochip immunoassay discriminating benign from malignant prostate disease.Cancer Res.2001,61:6029-6033.
9Li J,Zhang Z,Rosenzweig J.Chan DW Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.Clin Chem,2002 ,48:1296-304.
10Rosty C,Christa L,Kuzdzal S,et al.Identification of hepato-carcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.Cancer Res,2002,2:1868-1875.
